Insider Transactions in Q1 2023 at Colgate Palmolive CO (CL)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 13
2023
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
2,040
-24.27%
|
$144,840
$71.67 P/Share
|
Feb 27
2023
|
Michael B Polk Director |
SELL
Open market or private sale
|
Direct |
5,559
-19.08%
|
$405,807
$73.48 P/Share
|
Feb 27
2023
|
Michael B Polk Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+16.37%
|
$404,913
$71.65 P/Share
|
Feb 27
2023
|
John T Cahill Director |
SELL
Open market or private sale
|
Direct |
5,703
-18.96%
|
$416,319
$73.83 P/Share
|
Feb 27
2023
|
John T Cahill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+15.94%
|
$404,913
$71.65 P/Share
|
Feb 21
2023
|
C Martin Harris Director |
SELL
Open market or private sale
|
Direct |
5,703
-25.11%
|
$422,022
$74.25 P/Share
|
Feb 21
2023
|
C Martin Harris Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+20.07%
|
$404,913
$71.65 P/Share
|
Feb 17
2023
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
4,922
-8.54%
|
$359,306
$73.31 P/Share
|
Feb 17
2023
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,009
-10.48%
|
$73,657
$73.25 P/Share
|
Feb 17
2023
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
1,515
-15.27%
|
$110,595
$73.3 P/Share
|
Feb 16
2023
|
Gregory Malcolm EVP and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-4.39%
|
$30,168
$72.77 P/Share
|
Feb 16
2023
|
Gregory Malcolm EVP and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+9.59%
|
-
|
Feb 16
2023
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
SELL
Payment of exercise price or tax liability
|
Direct |
3,138
-19.29%
|
$225,936
$72.77 P/Share
|
Feb 16
2023
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
BUY
Grant, award, or other acquisition
|
Direct |
9,361
+36.53%
|
-
|
Feb 16
2023
|
Noel R. Wallace Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,146
-7.9%
|
$1,522,512
$72.77 P/Share
|
Feb 16
2023
|
Noel R. Wallace Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,461
+14.51%
|
-
|
Feb 16
2023
|
Jennifer Daniels CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,361
+13.97%
|
-
|
Feb 16
2023
|
Sally Massey Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,666
+14.76%
|
-
|
Feb 16
2023
|
John W Kooyman Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
2,778
+21.88%
|
-
|
Feb 16
2023
|
Prabha Parameswaran Grp Pres, Growth & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
3,807
-23.45%
|
$274,104
$72.77 P/Share
|
Feb 16
2023
|
Prabha Parameswaran Grp Pres, Growth & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
9,361
+36.57%
|
-
|
Feb 15
2023
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,054
-27.89%
|
$507,888
$72.7 P/Share
|
Feb 01
2023
|
Lorrie M Norrington Director |
SELL
Open market or private sale
|
Direct |
5,703
-17.18%
|
$422,022
$74.13 P/Share
|
Feb 01
2023
|
Lorrie M Norrington Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,703
+14.66%
|
$404,913
$71.65 P/Share
|
Jan 03
2023
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
271
+0.98%
|
$21,138
$78.4 P/Share
|
Jan 03
2023
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
119
+1.67%
|
$9,282
$78.4 P/Share
|
Jan 03
2023
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
271
+1.04%
|
$21,138
$78.4 P/Share
|